Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cristina P Rodriguez

Showing results (21-30 of 61) with videos related to

Pageof 7
Sort By:
The Laryngoscope|April 10, 2009
Does vocal cord fixation preclude nonsurgical management of laryngeal cancer?C Arturo Solares, Benjamin Wood, Cristina P Rodriguez, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 12, 2009
Mature results from a phase II trial of postoperative concurrent chemoradiotherapy for poor prognosis cancer of the esophagus and gastroesophageal junctionDavid J Adelstein, Thomas W Rice, Lisa A Rybicki, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 17, 2009
A phase II study of perioperative concurrent chemotherapy, gefitinib, and hyperfractionated radiation followed by maintenance gefitinib in locoregionally advanced esophagus and gastroesophageal junction cancerCristina P Rodriguez, David J Adelstein, Thomas W Rice, et al.
Head & Neck|August 16, 2008
Clinical predictors of larynx preservation after multiagent concurrent chemoradiotherapyCristina P Rodriguez, David J Adelstein, Lisa A Rybicki, et al.
Cancer|April 19, 2018
Racial disparity in oncologic and quality-of-life outcomes in patients with locally advanced head and neck squamous cell carcinomas enrolled in a randomized phase 2 trialMargaret K Guerriero, Mary W Redman, Kelsey K Baker, et al.
Laryngoscope Investigative Otolaryngology|April 18, 2022
A phase I/II trial of concurrent immunotherapy with chemoradiation in locally advanced larynx cancerAndrew J Frankart, Nooshin Hashemi Sadraei, Brad Huth, et al.
International Journal of Particle Therapy|January 5, 2026
Outcomes After Fast Neutron Therapy for Locally Advanced Base of Tongue Adenoid Cystic CarcinomaAnthony K Heng, August Anderson, Robert D Stewart, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 28, 2019
Management of the Neck in Squamous Cell Carcinoma of the Oral Cavity and Oropharynx: ASCO Clinical Practice GuidelineShlomo A Koyfman, Nofisat Ismaila, Doug Crook, et al.
The Laryngoscope|December 2, 2016
Predictors of outcome with cetuximab and paclitaxel for head and neck squamous cell carcinomaBruna Pellini Ferreira, Mary Redman, Kelsey K Baker, et al.
Head & Neck|November 22, 2022
Neutrophil to lymphocyte ratio and peripheral blood biomarkers correlate with survival outcomes but not response among head and neck and salivary cancer treated with pembrolizumab and vorinostatCassie Pan, Qian Vicky Wu, Jenna Voutsinas, et al.
Pageof 7

Showing results (21-30 of 61) with videos related to

Sort By:
Pageof 7
The Laryngoscope|April 10, 2009
Does vocal cord fixation preclude nonsurgical management of laryngeal cancer?C Arturo Solares, Benjamin Wood, Cristina P Rodriguez, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 12, 2009
Mature results from a phase II trial of postoperative concurrent chemoradiotherapy for poor prognosis cancer of the esophagus and gastroesophageal junctionDavid J Adelstein, Thomas W Rice, Lisa A Rybicki, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 17, 2009
A phase II study of perioperative concurrent chemotherapy, gefitinib, and hyperfractionated radiation followed by maintenance gefitinib in locoregionally advanced esophagus and gastroesophageal junction cancerCristina P Rodriguez, David J Adelstein, Thomas W Rice, et al.
Head & Neck|August 16, 2008
Clinical predictors of larynx preservation after multiagent concurrent chemoradiotherapyCristina P Rodriguez, David J Adelstein, Lisa A Rybicki, et al.
Cancer|April 19, 2018
Racial disparity in oncologic and quality-of-life outcomes in patients with locally advanced head and neck squamous cell carcinomas enrolled in a randomized phase 2 trialMargaret K Guerriero, Mary W Redman, Kelsey K Baker, et al.
Laryngoscope Investigative Otolaryngology|April 18, 2022
A phase I/II trial of concurrent immunotherapy with chemoradiation in locally advanced larynx cancerAndrew J Frankart, Nooshin Hashemi Sadraei, Brad Huth, et al.
International Journal of Particle Therapy|January 5, 2026
Outcomes After Fast Neutron Therapy for Locally Advanced Base of Tongue Adenoid Cystic CarcinomaAnthony K Heng, August Anderson, Robert D Stewart, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 28, 2019
Management of the Neck in Squamous Cell Carcinoma of the Oral Cavity and Oropharynx: ASCO Clinical Practice GuidelineShlomo A Koyfman, Nofisat Ismaila, Doug Crook, et al.
The Laryngoscope|December 2, 2016
Predictors of outcome with cetuximab and paclitaxel for head and neck squamous cell carcinomaBruna Pellini Ferreira, Mary Redman, Kelsey K Baker, et al.
Head & Neck|November 22, 2022
Neutrophil to lymphocyte ratio and peripheral blood biomarkers correlate with survival outcomes but not response among head and neck and salivary cancer treated with pembrolizumab and vorinostatCassie Pan, Qian Vicky Wu, Jenna Voutsinas, et al.
Pageof 7